We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SUMO2 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
427.9
Number of samples
349
Samples
Sample
Description
TPM
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
1325.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
944.7
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
928.0
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
908.3
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
884.3
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
866.8
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
860.5
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
857.9
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
830.5
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
824.8
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
822.1
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
795.6
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
762.3
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
762.0
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
758.9
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
744.4
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
743.2
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
736.8
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
733.4
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
731.7
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
728.3
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
727.4
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
726.2
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
726.1
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
720.3
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
715.6
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
696.3
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
696.1
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
693.7
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
678.9
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
663.6
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
660.4
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
658.4
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
657.7
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
656.6
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
656.0
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
654.2
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
651.2
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
649.7
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
641.4
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
641.0
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
639.3
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
638.6
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
624.9
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
622.2
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
612.5
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
610.2
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
602.1
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
595.0
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
594.0
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
590.7
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
590.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
583.5
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
582.2
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
581.6
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
578.8
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
576.8
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
573.9
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
569.4
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
569.3
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
568.6
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
561.5
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
561.0
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
557.0
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
556.0
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
553.5
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
553.3
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
546.7
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
543.7
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
542.8
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
538.2
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
536.1
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
535.4
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
532.2
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
530.2
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
529.8
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
528.8
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
526.4
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
526.3
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
525.6
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
523.0
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
522.9
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
522.8
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
522.7
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
521.1
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
520.3
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
516.3
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
516.1
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
515.1
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
514.3
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
512.4
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
510.2
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
509.8
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
504.7
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
504.3
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
503.7
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
503.3
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
503.1
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
502.5
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
500.8
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
500.0
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
497.2
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
496.7
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
493.0
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
492.8
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
492.2
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
490.8
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
487.3
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
485.8
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
485.1
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
480.0
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
478.4
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
478.1
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
476.0
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
475.6
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
474.9
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
474.3
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
474.2
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
471.9
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
470.9
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
470.6
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
470.3
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
468.8
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
468.1
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
466.4
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
466.3
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
464.1
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
461.7
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
461.6
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
461.3
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
461.0
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
460.6
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
459.5
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
455.8
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
451.4
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
449.1
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
445.5
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
445.3
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
445.1
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
444.6
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
444.2
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
443.2
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
443.1
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
442.9
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
441.7
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
441.5
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
441.5
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
439.9
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
437.9
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
437.8
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
434.0
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
432.0
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
428.4
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
427.6
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
427.5
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
427.0
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
422.5
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
421.3
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
420.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
419.8
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
419.6
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
418.7
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
418.1
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
418.0
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
415.7
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
412.8
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
412.7
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
412.3
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
410.7
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
408.0
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
407.4
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
403.5
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
403.1
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
401.6
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
401.6
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
399.3
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
399.2
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
397.5
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
395.7
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
395.6
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
395.2
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
394.8
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
392.6
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
390.8
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
390.5
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
390.5
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
389.9
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
389.5
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
389.0
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
388.6
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
388.2
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
388.1
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
387.5
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
387.3
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
387.0
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
386.5
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
385.5
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
384.9
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
384.7
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
383.1
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
382.9
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
382.7
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
381.9
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
380.1
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
373.7
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
373.2
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
370.6
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
368.7
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
365.5
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
365.4
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
365.4
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
364.2
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
361.6
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
361.3
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
358.0
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
358.0
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
357.1
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
356.4
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
354.6
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
354.0
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
350.1
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
348.9
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
346.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
345.7
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
343.6
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
339.9
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
339.7
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
338.5
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
333.9
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
333.0
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
331.0
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
330.3
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
329.6
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
329.0
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
327.8
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
327.3
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
326.2
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
325.7
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
324.9
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
324.0
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
323.4
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
321.9
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
321.6
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
321.6
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
320.4
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
317.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
317.4
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
317.0
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
316.3
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
316.2
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
314.8
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
313.9
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
312.1
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
312.0
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
308.9
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
306.4
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
306.1
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
305.4
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
305.1
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
304.0
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
303.9
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
302.0
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
299.8
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
299.0
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
298.3
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
297.8
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
295.8
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
295.6
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
295.0
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
293.8
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
293.8
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
291.2
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
289.0
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
288.3
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
287.6
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
284.5
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
280.8
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
278.8
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
278.7
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
278.6
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
278.3
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
277.5
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
277.2
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
276.6
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
276.4
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
273.1
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
270.0
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
269.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
267.7
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
267.6
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
267.4
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
265.6
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
265.3
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
263.9
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
263.3
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
261.8
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
260.8
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
259.1
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
259.1
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
255.3
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
255.2
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
255.0
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
254.7
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
254.7
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
254.5
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
254.5
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
254.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
252.8
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
251.6
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
251.3
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
247.7
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
247.1
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
244.8
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
244.2
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
243.1
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
243.0
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
241.1
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
239.5
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
238.4
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
235.5
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
233.1
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
231.7
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
231.6
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
228.5
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
228.0
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
227.2
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
226.1
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
225.6
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
225.0
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
223.9
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
223.6
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
222.4
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
220.7
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
220.5
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
219.3
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
215.6
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
208.0
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
204.6
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
203.2
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
199.6
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
197.0
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
196.3
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
193.2
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
191.4
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
189.6
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
158.7
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
131.3
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
119.1
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SUMO2 is potential prognostic, high expression is favorable in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
203.2
Number of samples
81
Samples
Sample
Description
TPM
DO46586
0 years, female, NA, stage:III, dead, 1019 days
695.1
DO46380
0 years, female, NA, stage:III, dead, 1423 days
378.0
DO46588
0 years, female, NA, stage:III, dead, 438 days
375.7
DO46368
0 years, female, NA, stage:III, dead, 2879 days
349.8
DO46528
0 years, female, NA, stage:III, alive, 6139 days
346.2
DO46443
0 years, female, NA, stage:III, dead, 2464 days
344.6
DO46463
0 years, female, NA, stage:III, dead, 2451 days
299.4
DO46551
0 years, female, NA, stage:III, dead, 1055 days
293.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
279.7
DO46432
0 years, female, NA, stage:III, alive, 2218 days
270.2
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
263.1
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
259.6
DO46606
0 years, female, NA, stage:III, alive, 804 days
257.0
DO46533
0 years, female, NA, stage:III, alive, 3667 days
255.3
DO46338
0 years, female, NA, stage:III, dead, 596 days
252.0
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
249.5
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
246.8
DO46334
0 years, female, NA, stage:III, dead, 496 days
246.3
DO46568
0 years, female, NA, stage:III, dead, 320 days
241.3
DO46336
0 years, female, NA, stage:IV, dead, 664 days
239.4
DO46388
0 years, female, NA, stage:III, dead, 413 days
239.1
DO46332
0 years, female, NA, stage:III, dead, 689 days
232.7
DO46412
0 years, female, NA, stage:III, dead, 597 days
232.2
DO46390
0 years, female, NA, stage:III, dead, 374 days
229.3
DO46386
0 years, female, NA, stage:III, dead, 1162 days
228.9
DO46571
0 years, female, NA, stage:III, dead, 243 days
226.9
DO46364
0 years, female, NA, stage:III, dead, 806 days
223.2
DO46408
0 years, female, NA, stage:III, dead, 489 days
221.5
DO46348
0 years, female, NA, stage:IV, dead, 287 days
221.5
DO46327
0 years, female, NA, stage:III, dead, 184 days
220.4
DO46358
0 years, female, NA, stage:III, dead, 423 days
219.9
DO46392
0 years, female, NA, stage:III, dead, 628 days
218.1
DO46493
0 years, female, NA, stage:IV, alive, 839 days
216.4
DO46561
0 years, female, NA, stage:III, dead, 195 days
211.0
DO46330
0 years, female, NA, stage:III, dead, 684 days
209.8
DO46370
0 years, female, NA, stage:III, dead, 1727 days
206.4
DO46325
0 years, female, NA, stage:III, dead, 477 days
201.1
DO46453
0 years, female, NA, stage:III, dead, 3294 days
201.0
DO46538
0 years, female, NA, stage:III, dead, 1527 days
198.5
DO46340
0 years, female, NA, stage:III, dead, 616 days
194.6
DO46352
0 years, female, NA, stage:III, dead, 677 days
190.4
DO46581
0 years, female, NA, stage:III, dead, 408 days
189.2
DO46591
0 years, female, NA, stage:III, dead, 195 days
189.1
DO46448
0 years, female, NA, stage:III, dead, 654 days
184.8
DO46328
0 years, female, NA, stage:III, dead, 972 days
181.8
DO46378
0 years, female, NA, stage:III, alive, 843 days
181.6
DO46576
0 years, female, NA, stage:III, alive, 133 days
177.1
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
177.0
DO46382
0 years, female, NA, stage:IV, dead, 311 days
176.7
DO46362
0 years, female, NA, stage:III, dead, 1639 days
172.8
DO46566
0 years, female, NA, stage:III, dead, 673 days
169.8
DO46326
0 years, female, NA, stage:III, dead, 701 days
169.3
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
168.4
DO46331
0 years, female, NA, stage:III, dead, 612 days
166.6
DO46346
0 years, female, NA, stage:III, dead, 1187 days
162.6
DO46374
0 years, female, NA, stage:III, dead, 1409 days
161.6
DO46376
0 years, female, NA, stage:III, dead, 1430 days
159.6
DO46602
0 years, female, NA, stage:III, dead, 205 days
155.8
DO46398
0 years, female, NA, stage:III, alive, 437 days
155.8
DO46396
0 years, female, NA, stage:III, dead, 583 days
153.9
DO46354
0 years, female, NA, stage:III, dead, 843 days
153.4
DO46546
0 years, female, NA, stage:III, dead, 1889 days
150.8
DO46508
0 years, female, NA, stage:III, dead, 2101 days
146.6
DO46356
0 years, female, NA, stage:III, dead, 911 days
146.4
DO46518
0 years, female, NA, stage:III, alive, 2960 days
145.9
DO46350
0 years, female, NA, stage:III, dead, 886 days
145.3
DO46402
0 years, female, NA, stage:III, dead, 511 days
140.6
DO46372
0 years, female, NA, stage:III, dead, 1326 days
140.1
DO46560
0 years, female, NA, stage:IV, dead, 286 days
138.6
DO46404
0 years, female, NA, stage:III, dead, 690 days
137.2
DO46597
0 years, female, NA, stage:III, dead, 393 days
132.5
DO46329
0 years, female, NA, stage:III, dead, 1699 days
125.2
DO46468
0 years, female, NA, stage:III, alive, 2776 days
124.1
DO46342
0 years, female, NA, stage:III, dead, 1398 days
120.1
DO46400
0 years, female, NA, stage:III, dead, 719 days
115.9
DO46344
0 years, female, NA, stage:III, dead, 642 days
111.7
DO46384
0 years, female, NA, stage:III, dead, 614 days
104.6
DO46366
0 years, female, NA, stage:III, dead, 2054 days
71.1
DO46611
0 years, female, NA, stage:III, dead, 734 days
60.4
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
59.1
DO46333
0 years, female, NA, stage:III, dead, 359 days
57.7
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.5
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.5
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.3
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.2
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.2
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.2
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.1
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.1
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.1
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.2
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.2
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.2
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.3
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.3
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.4
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.4
15524912-685a-47ce-a824-567848_D2
Tumor
-0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.4
285fed94-1495-448e-879b-b55de9_D2
Tumor
-0.4
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.4
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.5
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.5
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.5
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.5
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.5
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.5
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.6
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.6
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.6
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-0.6
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.6
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.6
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.7
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.7
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.7
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.8
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.8
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.8
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.8
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.8
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.8
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.8
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.8
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.9
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.9
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.9
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.9
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.9
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.9
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-1.0
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-1.0
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-1.0
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-1.0
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-1.0
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-1.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-1.1
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-1.1
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-1.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-1.1
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-1.1
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-1.1
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-1.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-1.2
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-1.2
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-1.2
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-1.2
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-1.2
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-1.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-1.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-1.3
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-1.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-1.4
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-1.4
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-1.5
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-1.5
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-1.5
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-1.6
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-1.6
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-1.6
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-1.6
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-1.7
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-1.8
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-1.8
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-1.8
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-1.8
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-1.8
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-1.8
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-1.8
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-1.9
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-1.9
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-2.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-2.0
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-2.1
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-2.1
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-2.2
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-2.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-2.3
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-2.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-2.3
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-2.3
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-2.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-2.9
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.